|本期目录/Table of Contents|

[1]王 菲,高永英,武艳玮,等.构建干扰多梳状蛋白2的人胶质瘤U251细胞系[J].宁夏医科大学学报,2019,(06):556-560.[doi:10.16050/j.cnki.issn1674-6309.2019.06.004]
 WANG Fei,GAO Yongying,WU Yanwei,et al.Construction of Human Glioma U251 Cell Line that Interferes with Polycomb Like 2[J].Ningxia Medical University,2019,(06):556-560.[doi:10.16050/j.cnki.issn1674-6309.2019.06.004]
点击复制

构建干扰多梳状蛋白2的人胶质瘤U251细胞系(PDF)
分享到:

《宁夏医科大学学报》[ISSN:1005-8486/CN:64-1029/R]

卷:
期数:
2019年06期
页码:
556-560
栏目:
论著
出版日期:
2019-06-30

文章信息/Info

Title:
Construction of Human Glioma U251 Cell Line that Interferes with Polycomb Like 2
文章编号:
1674-6309(2019)06-0556-05
作者:
王 菲1 高永英2 武艳玮1 徐丽珲1 马 杰1 刘 焕3 曹相玫1
(1. 宁夏医科大学基础医学院病理学系,银川 750004; 2. 宁夏回族自治区人民医院神经内科,银川 750002; 3. 西安医学院基础医学部,西安 710021)
Author(s):
WANG Fei1 GAO Yongying2 WU Yanwei1 XU Lihui1 MA Jie1 LIU Huan3 CAO Xiangmei1
(1. Department of Pathology, School of Basic Medical Sciences,Ningxia Medical University, Yinchuan 750004,China; 2. Department of Neurology, Ningxia People’s Hospital, Yinchuan 750004, China; 3. Institute of Basic Medicine Science,Xi’an Medical University,Xi’an 710021,China)
关键词:
多梳状蛋白2U251细胞shRNAmicroRNA-30胶质瘤
Keywords:
polycomb like 2U251 cells shRNAmicroRNA-30glioma
分类号:
R739.41
DOI:
10.16050/j.cnki.issn1674-6309.2019.06.004
文献标志码:
A
摘要:
目的 建立稳定干扰多梳状蛋白2(polycomb like 2,PCL2)的人胶质瘤U251细胞系。方法 针对PCL2基因的shRNA克隆至miR30前体骨架shRNA表达载体,用PCR鉴定载体构建成功后转入HEK293细胞,得到重组腺病毒Ad5-E1-AmU6-PCL2 shRNA-E3-CMV-eGFP;将重组腺病毒转染至U251细胞中,分组为空白对照组、空载体组和PCL2 shRNA组,滴度梯度设置为MOI(20∶1,50∶1,100∶1),使用荧光显微镜观察腺病毒感染效率;用Western blot检测U251细胞内shRNA PCL2表达载体的基因沉默效率。结果 使用小RNA干扰技术,成功构建了表达PCL2 shRNA的重组腺病毒;荧光显微镜观察发现MOI(50∶1)时,U251细胞感染效率最高,细胞生长状态良好。Western blot结果显示PCL2 shRNA重组腺病毒组的PCL2蛋白水平较空白对照组和空载体组明显降低,以100∶1时的PCL2表达量最低,干扰效果最显著。结论 成功构建的PCL2 shRNA重组腺病毒能够在体外有效感染U251细胞,降低U251细胞中PCL2的蛋白表达并筛选出稳定沉默的细胞系。
Abstract:
Objective To establish a human glioma U251 cell line stably interfering with polycomb like 2 (PCL2) . Methods The shRNA of PCL2 gene was cloned into the shRNA expression vector of mir30 precursor skeleton. The PCR identification vector was successfully constructed and then transferred into HEK293 cells for preparation and purification. The recombinant adenovirus Ad5-E1-AmU6-PCL2 shRNA-E3-CMV-eGFP was obtained. The recombinant adenovirus was transfected into U251 cells and divided into blank control group, empty vector group and PCL2 shRNA group. The titer gradient was set to MOI(20∶1; 50∶1; 100 ∶1). The efficiency of adenovirus infection was observed by fluorescence microscope. Western blot was used to detect the gene silencing efficiency of shRNA PCL2 expression vector in U251 cells. Results The recombinant adenovirus expressing PCL2 shRNA was successfully constructed by using small RNA interference technique. Fluorescence microscopy showed that U251 cells had the highest infection efficiency and good growth state when MOI(50∶1) was observed. Western blot showed that the level of PCL2 protein in PCL2 shRNA recombinant adenoviral group was significantly lower than that in blank control group and empty vector group,and the expression of PCL2 was the lowest at 100∶1, and the interference effect was the most significant. Conclusion The successfully constructed PCL2 shRNA recombinant adenovirus can effectively infect U251 cells in vitro, reduce the expression of PCL2 protein in U251 cells and screen stable silent cell lines.

参考文献/References:

[1] Li X,Isono K,Yamada D,et al. Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes[J]. Mol Cell Biol,2011,31(2):351-364.
[2] Walker E,Chang W Y,Hunkapiller J,et al. Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation[J]. Cell Stem Cell,2010,6(2):153-166.
[3] Walker E,Manias JL,Chang WY,et al. PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem cells[J]. Cell Cycle,2014,10(1):45-51.
[4] Paddison PJ,Caudy AA,Bernstein E,et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells[J]. Genes Dev,2002,16(8):948-958.
[5] Brummelkamp TR,Bernards R,Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science,2002,296(5567):550-553.
[6] Yu F,Deng H,Yao H,et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells[J]. Oncogene,2010,29(29):4194-4204.
[7] Bauer M,Kinkl N,Meixner A,et al. Prevention of interferon-stimulated gene expression using microRNA-designed hairpins[J]. Gene Ther,2009,16(1):142-147.
[8] Cullen BR. Induction of stable RNA interference in mammalian cells[J]. Gene Ther,2006,13(6):503-508.
[9] Mu W,Starmer J,Yee D,et al. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation[J]. Epigenetics Chromatin,2018,11(1):71.
[10] Williams SC. Epigenetics[J]. Proceedings of the national academy of sciences of the United States of America,2013,110(9):3209.
[11] Christofides A,Karantanos T,Bardhan K,et al. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2[J]. Oncotarget,2016,7(51):85624-85640.
[12] Margueron R,Reinberg D. The Polycomb complex PRC2 and its mark in life[J]. Nature,2011,469(7330):343-349.
[13] Rothberg J,Maganti HB,Jrade H,et al. Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis[J]. Cell Discov,2018,4:21.
[14] Maganti HB,Jrade H,Cafariello C,et al. Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy[J]. Cancer Discovery,2018,8(11):1376-1389.
[15] Nayerossadat N,Maedeh T,Ali PA.Viral and nonviral delivery systems for gene delivery[J]. Advanced Biomedical Research,2012,1(1):27.
[16] Thomas CE,Ehrhardt A,Kay MA. Progress and problems with the use of viral vectors for gene therapy[J]. Nat Rev Genet,2003,4(5):346-358.
[17] Boden D,Pusch O,Silbermann R,et al. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins[J]. Nucleic Acids Res, 2004,32(3):1154-1158.
[18] Zeng Y,Wagner EJ,Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells[J]. Mol Cell,2002,9(6):1327-1333.

相似文献/References:

[1]薛皓予,刘文庆,尚明华,等.胶质瘤患者肿瘤组织中IGF2BP2的表达及临床意义[J].宁夏医科大学学报,2014,(05):487.
 XUE Haoyu,LIU Wenqing,SHANG Minghua,et al.The Expression and Clinical Significance of IGF2BP2 Gene in Tumor Tissues of Patients with Glioma[J].Ningxia Medical University,2014,(06):487.
[2]任平,张贺林,牛建国,等.STAT3基因shRNA慢病毒载体的构建与鉴定[J].宁夏医科大学学报,2014,(03):260.
 REN Ping,ZHANG Helin,NIU Jianguo,et al.Construction of STAT3 shRNA Lentiviral Vector[J].Ningxia Medical University,2014,(06):260.
[3]尹磊,王成泉,王珺,等.Per2-shRNA慢病毒构建及嘌呤霉素筛选Per2低表达的细胞株[J].宁夏医科大学学报,2014,(03):252.
 YIN Lei,WANG Chengquan,WANG Jun,et al.Constructing Per2-shRNA Lentiviral and Selecting Low-expression Cell Lines of Per2 with Puromycin[J].Ningxia Medical University,2014,(06):252.
[4]王占伟,乔卫军,赵 巍,等.重组穿梭质粒pAdTrack-cmv-rHSG载体的构建及鉴定[J].宁夏医科大学学报,2011,(02):119.
 WANG Zhan-wei,QIAO Wei-jun,ZHAO Wei,et al.Construction and Identification of Recombinant Plasmid pAdTrack-cmv-rHSG Encoding the Rat rHSG Gene[J].Ningxia Medical University,2011,(06):119.
[5]买正军,孙涛,夏玉成,等.胶质瘤Caspase-3表达与细胞凋亡和增殖的关系[J].宁夏医科大学学报,2009,(06):768.
[6]李虎年,刘南平.神经电生理监测技术在功能区胶质瘤术中定位的应用[J].宁夏医科大学学报,2009,(05):699.
[7]高 鹏,张 春,赵 巍,等.重组腺病毒载体对大鼠胶质瘤细胞转染效率的影响[J].宁夏医科大学学报,2013,(12):1322.
 GAO Peng,ZHANG Chun,ZHAO Wei,et al.Infection Efficiency of Rat C6 Cells Infected with Recombinant Adenovirus Vectors[J].Ningxia Medical University,2013,(06):1322.
[8]郭晖,王占伟,郝文炯,等.大鼠HSG基因重组腺病毒载体的构建及鉴定[J].宁夏医科大学学报,2013,(06):679.
 GUO Hui,WANG Zhan-wei,HAO Wen-jiong,et al.[J].Ningxia Medical University,2013,(06):679.
[9]杨光飞,米成嵘,王文,等.术中超声在脑胶质瘤手术中的应用价值[J].宁夏医科大学学报,2013,(06):655.
 YANG Guang-fei,MI Cheng-rong,WANG Wen.[J].Ningxia Medical University,2013,(06):655.
[10]李张珂,李延辉,王 凡,等.大鼠胶质瘤细胞中生物钟基因Period2的生物节律性研究[J].宁夏医科大学学报,2013,(05):485.
 LI Zhang-ke,LI Yan-hui,WANG Fan,et al.The Biological Rhythms of CircadianClock Gene Period2 in Glioma Cells[J].Ningxia Medical University,2013,(06):485.

备注/Memo

备注/Memo:
收稿日期:2019-02-13
基金项目:国家自然科学基金(81460433);宁夏自然科学基金 (NZ15177);宁夏高等学校一流学科建设(宁夏医科大学西部一流建设学科基础医学)资助项目(NXYLXK2017B07);陕西省自然科学基础研究计划-青年人才项目(2016JQ8001)
作者简介:王菲(1993-),女,宁夏人,在读硕士研究生,研究方向:脑肿瘤分子病理学及脑缺血疾病机制。
通信作者:曹相玫(1976-),副教授,博士,研究方向:脑肿瘤分子病理学及脑缺血疾病机制。E-mail:caoxm.nxmu@163.com
更新日期/Last Update: 2019-06-30